Welcome to our dedicated page for NOVONIX SEC filings (Ticker: NVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
NOVONIX Limited (NASDAQ: NVX, ASX: NVX) files reports with the U.S. Securities and Exchange Commission as a foreign private issuer under Commission File Number 001-41208. On this SEC filings page, Stock Titan surfaces NOVONIX’s regulatory submissions, including Form 6-K current reports that transmit key corporate documents and market announcements.
NOVONIX’s recent Form 6-K filings reference items such as applications for quotation of securities (Appendix 2A), notifications of cessation of securities (Appendix 3H), notifications of issue or conversion of unquoted equity securities (Appendix 3G), changes in substantial holdings, and quarterly activities and cash flow reports. These documents provide detail on NOVONIX’s capital structure changes, equity issuance or cessation events, and operational and cash flow updates.
The company’s filings also identify its principal executive office in Brisbane, Queensland, Australia, and confirm its status as a foreign issuer with securities listed on NASDAQ. Through these filings, NOVONIX reports on matters connected to its battery materials and technology activities, including synthetic graphite manufacturing projects and related financing or governance actions disclosed to investors via attached exhibits.
On Stock Titan, NOVONIX filings are paired with AI-powered summaries that highlight the main points of each document in accessible language. Users can quickly see what type of filing NOVONIX has submitted, the nature of any security issuances or changes, and references to significant corporate announcements included as exhibits. Real-time updates from the EDGAR system, combined with these summaries, help readers navigate NOVONIX’s regulatory history and understand how its SEC reporting aligns with its broader business developments.
NOVONIX Limited filed a quarterly activities and cash flow update showing continued investment in battery materials alongside higher funding. Operating activities used $9.7M in cash for the quarter, while capital expenditure reached $13.4M, mainly on the Riverside anode materials facility.
Financing inflows from unsecured convertible debentures totaled $49.4M this quarter, lifting cash and equivalents to $81.3M as of 31 December 2025, or an estimated 8.4 quarters of funding at the current burn rate. The company completed its full $100M Yorkville debenture program in 2025.
Commercially, NOVONIX advanced its anode and cathode platforms, delivering over 100 synthetic graphite samples to 15 customers and 10 cathode samples to seven OEMs and Tier‑1 battery makers, and launched a UHPC Calibration Module. Offsetting this, Stellantis terminated its large offtake agreement, while NOVONIX remains focused on Panasonic, PowerCo and other prospects amid supportive U.S. trade actions on Chinese graphite.
Novonix Limited filed a Form 6-K as a foreign private issuer for December 2025. The filing mainly forwards an exhibit, Appendix 2A, which is an application for quotation of securities dated December 18, 2025. The report is signed by the Chief Financial Officer, Robert Long.